Sector: Pharmaceutical PreparationsIndustry: BiotechnologyCountry: AUExchange: Nasdaq
DilutionScan read 58 of KAZIA THERAPEUTICS LTD's SEC filings and found 11 warrant series, 1 convertible, 3 ATM programs, 1 equity line, 4 shelf registrations, 5 S-1 registrations and 2 completed offerings on file for KZIA. The latest dilution event on file is a warrant issuance on Aug 31, 2026. Analysis updated Oct 6, 2026.
DilutionScan ProEvery instrument in full ยท $59/mo
Covered companies in Biotechnology. All tickers A to Z
EQEquillium, Inc.
ARMPArmata Pharmaceuticals, Inc.
ANIXAnixa Biosciences, Inc.
OTLKOutlook Therapeutics, Inc.
NKTXNkarta, Inc.
VYGRVoyager Therapeutics, Inc.
AVXLAnavex Life Sciences Corp.
HURATuHURA Biosciences, Inc.
PYPDPolyPid Ltd. Ordinary Shares
LENZLENZ Therapeutics, Inc.
PMVPPMV Pharmaceuticals, Inc.
NMRANeumora Therapeutics, Inc. Common Stock
NERVMinerva Neurosciences, Inc.
BDTXBlack Diamond Therapeutics, Inc.
IMUXImmunic, Inc.